ketoprofen has been researched along with Lung Neoplasms in 2 studies
Ketoprofen: An IBUPROFEN-type anti-inflammatory analgesic and antipyretic. It is used in the treatment of rheumatoid arthritis and osteoarthritis.
ketoprofen : An oxo monocarboxylic acid that consists of propionic acid substituted by a 3-benzoylphenyl group at position 2.
Lung Neoplasms: Tumors or cancer of the LUNG.
Excerpt | Relevance | Reference |
---|---|---|
"In conclusion, the topical treatment of osteosarcoma with KP decreased the expression of MMP-2 and VEGF, thus resulting in the suppression of tumor growth and pulmonary metastasis." | 5.35 | Ketoprofen in topical formulation decreases the matrix metalloproteinase-2 expression and pulmonary metastatic incidence in nude mice with osteosarcoma. ( Aizawa, J; Kamei, S; Masuno, H; Miyawaki, J; Miyazaki, T; Norimatsu, Y; Sakayama, K; Tamashiro, S; Yamamoto, H, 2009) |
"In conclusion, the topical treatment of osteosarcoma with KP decreased the expression of MMP-2 and VEGF, thus resulting in the suppression of tumor growth and pulmonary metastasis." | 1.35 | Ketoprofen in topical formulation decreases the matrix metalloproteinase-2 expression and pulmonary metastatic incidence in nude mice with osteosarcoma. ( Aizawa, J; Kamei, S; Masuno, H; Miyawaki, J; Miyazaki, T; Norimatsu, Y; Sakayama, K; Tamashiro, S; Yamamoto, H, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zhang, X | 1 |
Bian, J | 1 |
Li, X | 1 |
Wu, X | 1 |
Dong, Y | 1 |
You, Q | 1 |
Kamei, S | 1 |
Sakayama, K | 1 |
Tamashiro, S | 1 |
Aizawa, J | 1 |
Miyawaki, J | 1 |
Miyazaki, T | 1 |
Yamamoto, H | 1 |
Norimatsu, Y | 1 |
Masuno, H | 1 |
2 other studies available for ketoprofen and Lung Neoplasms
Article | Year |
---|---|
2-Substituted 3,7,8-trimethylnaphtho[1,2-b]furan-4,5-diones as specific L-shaped NQO1-mediated redox modulators for the treatment of non-small cell lung cancer.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Death; Cell Line, Tumor; Cell Proliferat | 2017 |
Ketoprofen in topical formulation decreases the matrix metalloproteinase-2 expression and pulmonary metastatic incidence in nude mice with osteosarcoma.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antigens, CD34; Apoptosis | 2009 |